Resistance to Targeted Anti-Cancer Therapeutics - Resistance to Targeted Therapies in Lymphomas
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 0)

H-INDEX

(FIVE YEARS 0)

Published By Springer International Publishing

9783030244231, 9783030244248

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Resistance to Histone Deacetylase Inhibitors in the Treatment of Lymphoma

Resistance to Targeted Anti-Cancer Therapeutics - Resistance to Targeted Therapies in Lymphomas ◽

10.1007/978-3-030-24424-8_5 ◽

2019 ◽

pp. 87-110 ◽

Cited By ~ 1

Author(s):

Allyson Flower ◽

Oussama Abla

Keyword(s):

Histone Deacetylase ◽

Histone Deacetylase Inhibitors

Download Full-text

Resistance to Bispecific T-Cell Engagers and Bispecific Antibodies

Resistance to Targeted Anti-Cancer Therapeutics - Resistance to Targeted Therapies in Lymphomas ◽

10.1007/978-3-030-24424-8_8 ◽

2019 ◽

pp. 181-192

Author(s):

Stacy L. Cooper ◽

Patrick A. Brown

Keyword(s):

T Cell ◽

Bispecific Antibodies

Download Full-text

Mechanisms of Glucocorticoid Response and Resistance in Lymphoid Malignancies

Resistance to Targeted Anti-Cancer Therapeutics - Resistance to Targeted Therapies in Lymphomas ◽

10.1007/978-3-030-24424-8_1 ◽

2019 ◽

pp. 1-26

Author(s):

Lauren K. Meyer ◽

Michelle L. Hermiston

Keyword(s):

Lymphoid Malignancies ◽

Glucocorticoid Response

Download Full-text

Resistance to Checkpoint Blockade Inhibitors and Immunomodulatory Drugs

Resistance to Targeted Anti-Cancer Therapeutics - Resistance to Targeted Therapies in Lymphomas ◽

10.1007/978-3-030-24424-8_7 ◽

2019 ◽

pp. 155-179

Author(s):

Anthony N. Audino ◽

Mitchell S. Cairo

Keyword(s):

Checkpoint Blockade ◽

Immunomodulatory Drugs

Download Full-text

Resistance to Bruton’s Tyrosine Kinase Signaling Pathway Targeted Therapies

Resistance to Targeted Anti-Cancer Therapeutics - Resistance to Targeted Therapies in Lymphomas ◽

10.1007/978-3-030-24424-8_6 ◽

2019 ◽

pp. 111-153 ◽

Cited By ~ 1

Author(s):

Yaya Chu ◽

Mitchell S. Cairo ◽

Auke Beishuizen

Keyword(s):

Tyrosine Kinase ◽

Signaling Pathway ◽

Targeted Therapies ◽

Bruton’S Tyrosine Kinase ◽

Kinase Signaling ◽

Bruton's Tyrosine Kinase ◽

Tyrosine Kinase Signaling ◽

Kinase Signaling Pathway

Download Full-text

Resistance to Antibody-Drug Conjugate

Resistance to Targeted Anti-Cancer Therapeutics - Resistance to Targeted Therapies in Lymphomas ◽

10.1007/978-3-030-24424-8_3 ◽

2019 ◽

pp. 57-69

Author(s):

Jessica Hochberg ◽

Sarah Alexander

Keyword(s):

Antibody Drug Conjugate ◽

Drug Conjugate ◽

Antibody Drug

Download Full-text

Resistance to Monoclonal Antibody Therapeutics in Lymphoma

Resistance to Targeted Anti-Cancer Therapeutics - Resistance to Targeted Therapies in Lymphomas ◽

10.1007/978-3-030-24424-8_2 ◽

2019 ◽

pp. 27-55

Author(s):

Matthew J. Barth ◽

Stanton C. Goldman

Keyword(s):

Monoclonal Antibody ◽

Antibody Therapeutics

Download Full-text

Resistance to Chimeric Antigen Receptor T-Cell Therapy

Resistance to Targeted Anti-Cancer Therapeutics - Resistance to Targeted Therapies in Lymphomas ◽

10.1007/978-3-030-24424-8_9 ◽

2019 ◽

pp. 193-203

Author(s):

Ana C. Xavier ◽

Luciano J. Costa

Keyword(s):

T Cell ◽

Cell Therapy ◽

Chimeric Antigen Receptor ◽

Antigen Receptor ◽

T Cell Therapy

Download Full-text

Resistance to Proteasome Inhibitor Therapy in Non-Hodgkin Lymphoma

Resistance to Targeted Anti-Cancer Therapeutics - Resistance to Targeted Therapies in Lymphomas ◽

10.1007/978-3-030-24424-8_4 ◽

2019 ◽

pp. 71-86

Author(s):

Rodney R. Miles ◽

Paul J. Galardy

Keyword(s):

Hodgkin Lymphoma ◽

Proteasome Inhibitor ◽

Inhibitor Therapy ◽

Non Hodgkin Lymphoma

Download Full-text

Resistance to Targeted Anti-Cancer Therapeutics - Resistance to Targeted Therapies in LymphomasLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Springer International Publishing

Resistance to Histone Deacetylase Inhibitors in the Treatment of Lymphoma

Resistance to Bispecific T-Cell Engagers and Bispecific Antibodies

Mechanisms of Glucocorticoid Response and Resistance in Lymphoid Malignancies

Resistance to Checkpoint Blockade Inhibitors and Immunomodulatory Drugs

Resistance to Bruton’s Tyrosine Kinase Signaling Pathway Targeted Therapies

Resistance to Antibody-Drug Conjugate

Resistance to Monoclonal Antibody Therapeutics in Lymphoma

Resistance to Chimeric Antigen Receptor T-Cell Therapy

Resistance to Proteasome Inhibitor Therapy in Non-Hodgkin Lymphoma

Resistance to Targeted Anti-Cancer Therapeutics - Resistance to Targeted Therapies in Lymphomas
Latest Publications